This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,743,905 units of the pharmaceutical product Remicade 100 mg vials. The award has a ceiling value of $6,165.12 and an ultimate completion date of May 30, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on a full and open competition basis without any set-aside designation.
Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Generated 8/28/24, 11:09 AM